 Anti-Bacterial Agents
"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 | | 1997 | 4 | 1 | 5 | | 1998 | 5 | 4 | 9 | | 1999 | 7 | 6 | 13 | | 2000 | 5 | 3 | 8 | | 2001 | 8 | 4 | 12 | | 2002 | 5 | 2 | 7 | | 2003 | 11 | 9 | 20 | | 2004 | 11 | 7 | 18 | | 2005 | 7 | 13 | 20 | | 2006 | 7 | 6 | 13 | | 2007 | 10 | 9 | 19 | | 2008 | 16 | 14 | 30 | | 2009 | 12 | 14 | 26 | | 2010 | 20 | 14 | 34 | | 2011 | 28 | 12 | 40 | | 2012 | 18 | 16 | 34 | | 2013 | 28 | 16 | 44 | | 2014 | 31 | 13 | 44 | | 2015 | 43 | 23 | 66 | | 2016 | 35 | 28 | 63 | | 2017 | 39 | 21 | 60 | | 2018 | 52 | 25 | 77 | | 2019 | 59 | 29 | 88 | | 2020 | 44 | 46 | 90 | | 2021 | 42 | 58 | 100 | | 2022 | 12 | 80 | 92 | | 2023 | 20 | 68 | 88 | | 2024 | 44 | 51 | 95 | | 2025 | 58 | 21 | 79 | | 2026 | 32 | 15 | 47 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Corley JM, Congel JH, Haist KC, Ochoa AE, Malcolm KC, Janssen WJ, Nick JA, Hisert KB. Tobramycin enhances Mycobacterium abscessus fitness through whiB7 induction. Proc Natl Acad Sci U S A. 2026 Sep 22; 123(38):e2626942123.
-
Long B, Yadav K, Rech MA, Gottlieb M. Advances in the diagnosis and management of skin and soft tissue infections. BMJ. 2026 Sep 10; 394:e100580.
-
Searns JB, Dunn A, Birkholz M, Hall M, Downes KJ, Hubbell BB, Kern-Goldberger AS, Markham JL, Rolsma SL, Wang ME, O'Leary ST, Dominguez SR, Parker SK, Kronman MP. Empiric MRSA Coverage for Children With Osteoarticular Infections: 2015 to 2024. Pediatrics. 2026 Sep 01; 158(3).
-
Wurcel A, Crabtree D, Asupoto O, Eippert M, Ngassa Y, Tam R, Kohut I, Foong KS, Stone V, Daudelin D, Bartels S, Blumenthal KG. Strategies to Increase Equitable Access to Penicillin Allergy Delabeling Interactions: A Qualitative Study. JAMA Netw Open. 2026 Sep 01; 9(9):e2633825.
-
Foong KS, Fowle L, Slider A, Campion M, Leaf J, Cumming M, Bolstorff B, Brandeburg C, McHale E, Reilly C, Beaulac K, Vazquez GA, Koethe B, Doron S, Alsoubani M. A Public Health Approach to Antimicrobial Stewardship in Long-term Care Facilities: A Multifaceted Program in Massachusetts. Clin Infect Dis. 2026 Jul 23; 83(1):e10-e17.
-
Salam ME, Chastain DB, Fish D, Henao-MartÃnez AF, Krsak M, Miller M, Morrisette T, Mueller S, Krsak M. Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections. Drugs. 2026 Sep; 86(9):1421-1434.
-
Williamson KS, Franklin MJ. Role of starvation survival response mechanisms on ribosome integrity, antibiotic tolerances, and virulence of Pseudomonas aeruginosa biofilms. NPJ Biofilms Microbiomes. 2026 Jul 08; 12(1).
-
Plattner AS, O'Leary S, Katz SE, Andersen LM, Facer EE, Jenkins TC, Stein AB, Thomas G, Koenig N, Frost HM. Differences in Antibiotic Prescribing Patterns for Children with Acute Otitis Media Based on Patient, Clinician, and Clinic Characteristics. J Pediatric Infect Dis Soc. 2026 Jul 06; 15(7).
-
Beck A, Driscoll J, Hoetzer K, Abraham AG, Conway R, Bakalar J, Johnston H, Czaja CA. Association between social vulnerability index and rates of carbapenem-resistant enterobacterales infections in the Denver metropolitan region, 2016-2019. Infect Control Hosp Epidemiol. 2026 Aug; 47(8):840-842.
-
Amajor V, Bwint A, Shein SL, Hume J, Rowan CM, Flygt LP, Malone MP, Stenson EK, Weiss SL, Zinter MS, Kannan S, Dahmer MK, Nofziger RA, Pai MP, Zuppa AF, Rhodes NJ, Hall MW, Scheetz MH, Downes KJ. Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling. Antimicrob Agents Chemother. 2026 Jul; 70(7):e0173625.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|